tiprankstipranks
Advertisement
Advertisement

Bioceres Crop Solutions Posts 3Q 2026 Loss as Revenues Slide During Post–Pro Farm Restructuring

Story Highlights
  • Bioceres’ fiscal third-quarter 2026 revenue dropped 23% to $39.4 million, driving a $10 million net loss and slightly negative adjusted EBITDA.
  • Following Pro Farm’s foreclosure and its classification as discontinued operations, Bioceres is cutting costs, managing liabilities, and reviewing its operations to refocus on core businesses.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Bioceres Crop Solutions Posts 3Q 2026 Loss as Revenues Slide During Post–Pro Farm Restructuring

Meet Samuel – Your Personal Investing Prophet

Bioceres Crop Solutions ( (BIOX) ) has provided an announcement.

Bioceres Crop Solutions reported fiscal third-quarter 2026 results on May 11, 2026, with revenues from continuing operations falling 23% year over year to $39.4 million and gross profit down 30% to $12.7 million. The company posted a net loss of $10.0 million and slightly negative adjusted EBITDA, as weaker crop protection demand, a sharp drop in seed and integrated product sales, and a non-recurring obsolescence charge in inoculants outweighed 15% growth in crop nutrition.

The quarter underscored the operational reset following January 2026’s foreclosure auction of its Pro Farm Group business, now treated as discontinued operations, and highlighted ongoing liability management measures including debt reprofiling and bond maturity extensions in Argentina. Management emphasized cost-cutting, working capital improvements, and a strategic review of continuing operations to streamline the organization and reallocate capital, moves that may reshape Bioceres’ risk profile and competitiveness amid litigation related to Pro Farm and persistent competitive pressures in crop protection.

The most recent analyst rating on (BIOX) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Bioceres Crop Solutions stock, see the BIOX Stock Forecast page.

Spark’s Take on BIOX Stock

According to Spark, TipRanks’ AI Analyst, BIOX is a Neutral.

The score is held down primarily by sharply weakened profitability and higher leverage, which reduce financial flexibility. Technicals also point to a pressured longer-term trend with negative momentum. Improved operating and free cash flow provides some support but is not enough to offset the scale of losses and balance-sheet risk, while valuation is difficult to judge due to negative earnings and no dividend data.

To see Spark’s full report on BIOX stock, click here.

More about Bioceres Crop Solutions

Bioceres Crop Solutions is an Argentina-based agricultural technology company that develops and commercializes productivity solutions aimed at regenerating agricultural ecosystems and improving crop resilience to climate change. Its portfolio spans crop protection, seed and integrated products, and crop nutrition, with a growing focus on microbeaded fertilizers and an asset-light seeds model across key global farming markets.

Average Trading Volume: 725,129

Technical Sentiment Signal: Sell

Current Market Cap: $29.73M

See more insights into BIOX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1